Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GABA transaminase (GABA-T) is a pyridoxal 5'-phosphate-dependent enzyme responsible for the degradation of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system. By degrading GABA, GABA-T helps regulate inhibitory signaling in the brain. Inhibition of GABA-T increases brain levels of GABA and is a therapeutic strategy for conditions like epilepsy. Mutations in the ABAT gene, which encodes GABA-T, can cause GABA-transaminase deficiency, leading to severe neurological symptoms.
Irreversible GABA-T inhibitor
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GABA transaminase enzyme (None).